of the secretory pathway and on the apical plasma membrane of FRT cells. Three-dimensional analyses further revealed Taar1 immunoreactivity in cilial extensions of postconfluent FRT cell cultures that had formed follicle-like structures. Conclusions: The results suggest Taar1 transport along the secretory pathway and its accumulation in the primary cilium of thyrocytes. These findings are of significance considering the increasing interest in the role of cilia in harboring functional GPCR. We hypothesize that thyronamines can reach and activate Taar1 in thyroid follicular epithelia by acting from within the thyroid follicle lumen, their potential site of synthesis, as part of a nonclassical mechanism of thyroid autoregulation.
Introduction
Taar1 belongs to the family of G-protein-coupled receptors (GPCR) [1] [2] [3] [4] [5] . However, concerning its ligand interactions the receptor is promiscuous [6] [7] [8] [9] [10] . Taar1 is activated by biogenic amines such as β-phenylethylamine, β-tryptamine and p -tyramine, and modulates the action of amphetamines [5, 7, 11] . In addition, a relative of the classical thyroid hormones (TH) T 3 and T 4 , namely 3-iodothyronamine (T 1 AM), has been identified as a Taar1 agonist in vitro [7, 10, 12] .
In contrast to a major interest in the action of thyronamines on peripheral TH target organs [for reviews see 10, [13] [14] [15] , the action of T 1 AM on the thyroid gland itself has received little attention. Likewise, the precise pattern of Taar1 tissue distribution and, in particular, where it is localized in thyroid epithelial cells, has not been studied in depth. Therefore, in this study we asked whether Taar1 is expressed in the rodent thyroid gland.
Thyroid epithelial cells are the main cell type composing thyroid follicles, the functional units enabling the thyroid gland to fulfill its tasks of iodine organification and maintenance of constant TH levels in the blood circulation. Thyroid follicles are spherical structures in which polarized thyrocytes face the extracellular follicle lumen with their apical plasma membrane domain. The prohormone thyroglobulin is synthesized by thyrocytes and, upon secretion and iodination, is stored within the lumen. TSH binds to the basolateral TSH receptor -the beststudied thyroidal GPCR -thereby triggering the sequential proteolytic processing of thyroglobulin mediated by cysteine cathepsins that act in the pericellular space close to the apical cell surface, including cilia, and within endocytic compartments of thyroid epithelial cells, resulting in thyroglobulin utilization for TH liberation [16] [17] [18] [19] .
Here, we asked whether Taar1 is expressed by thyrocytes in situ and FRT cells, a polarized nontransformed Fisher rat thyroid epithelial cell line [20, 21] , and, if so, where. FRT cells form tight monolayers and are characterized by apical and basolateral plasma membrane domains, making them well suited as an excellent thyroid epithelial cell model for trafficking studies [22] [23] [24] .
Immunofluorescence microscopy revealed the presence of Taar1 immunoreactivity in the compartments of the secretory pathway of mouse and rat thyrocytes in situ and in vitro. Taar1 immunoreactivity was additionally detected in a single prominent extension per FRT cell that was identified as the primary cilium by colocalization studies with acetylated α-tubulin. The apical pole localization of Taar1 in FRT cell cilia was maintained during dome formation in long-term cultures. Hence, the results of this study provide novel insights into the role that Taar1-mediated signaling at cilia might play in promoting the function of thyroid epithelial cells. We propose that endogenous ligand(s), including T 1 AM, are present in the thyroid follicle lumen, where they can trigger Taar1 signaling in situ.
Materials and Methods

Animals, Thyroid Tissue Sampling and Cryosectioning
Male taar1 -deficient mice or their C57BL6/J wild type (WT) littermates were kept in the animal facility of Jacobs University Bremen, Germany. The founder Taar1 -/-mice were provided by Dr. D.K. Grandy and genotyped as previously described (www. komp.org/geneinfo.php?geneid=81264). BALB/c mice and Fisher rats were purchased from Charles River, Cologne, Germany. Mice and rats were housed under standard conditions, with a 12/12 h light/dark cycle and water and food ad libitum. Testing was conducted in accordance with institutional guidelines in the S1-laboratories of Jacobs University Bremen (SfAFGJS Az. 513-30-00/2-15-32 and 522-27-11/3-1, 05-A20 and A21).
Mice or rats were deeply anesthetized by CO 2 inhalation or by using the inhalation anesthetic IsoFlou (Abbott GmbH & Co. KG, Wiesbaden-Delkenheim, Germany) before injection of 100 μl of 10% ketamine (CEVA Sante Animale, Düsseldorf, Germany) intraperitoneally. Perfusion was carried out through the heart with 0.9% NaCl, including 0.4 IU heparin per milliliter. The head and neck regions were immediately separated and placed on ice for the entire dissection procedure.
The dissected thyroid glands were fixed in 4% PFA in 200 m M HEPES, pH 7.4, and left overnight at 4 ° C, then cryopreservation was carried out by incubating in 0.5 M and afterwards in 1 M sucrose solution in phosphate-buffered saline (PBS), pH 7.4, with each step another 24 h at 4 ° C. Tissue samples were embedded in Jung tissue freezing medium (Leica Microsystems, Nussloch, Germany) and stored at -20 ° C until sectioning on a cryostat (Leica CM1900, Leica Microsystems) into 5-μm-thick sections and thawmounting on microscope slides.
Cell Culture FRT cells [20] were grown at 37 ° C and 5% CO 2 in a moisturized atmosphere, in Coons F-12 medium (Sigma-Aldrich, Steinheim, Germany) containing 2.68 mg/ml sodium bicarbonate and 5% fetal bovine serum (F7524, Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany), supplemented with a hormone mixture consisting of 2 μg/ml insulin (I6634, Sigma-Aldrich), 20 ng/ml Gly-His-Lys complex (G7387, Sigma-Aldrich), 3.62 ng/ml hydrocortisone (H0135, Sigma-Aldrich), 5 μg/ml transferrin (11107-018, Invitrogen, Darmstadt, Germany), and 10 ng/ml somatostatin (S1763, Sigma-Aldrich).
Indirect Immunofluorescence
FRT cells were cultured on ethanol-sterilized coverslips in 6-well plates (Sarstedt, Nümbrecht, Germany). In some experiments, cells were incubated with 1 μ M LysoTracker Red DND-99 (L-7528, Molecular Probes, Leiden, The Netherlands) in culture medium for 45 min at 37 ° C. Washing with culture medium twice for 3 min each was followed by a chase period of 30 min in complete cell culture medium and washes as described above before the cells were stained. The cells were fixed with 4% paraformaldehyde in 200 m M HEPES, pH 7.4, for 20 min at room temperature followed by 3 times 5-min incubation with calcium-and magnesiumfree PBS (CMF-PBS), i.e. 0.15 M NaCl, 2.7 m M KCl, 1.5 m M NaH 2 PO 4 , 8.1 m M Na 2 HPO 4 , pH 7.4. Permeabilization was performed with 0.1% saponin or 0.1% Triton X-100 in CMF-PBS for 5 min at room temperature. The residual embedding material of cryosections was washed out prior to the staining procedure by overnight incubation in PBS at 4 ° C.
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For blocking, 3% bovine serum albumin (BSA; Carl Roth GmbH, Karlsruhe, Germany) in CMF-PBS was used for 1 h at 37 ° C. The cells or sections were incubated with primary antibodies diluted in 0.1% BSA in CMF-PBS overnight at 4 ° C. The sections and cells were labeled with rabbit anti-mouse Taar1, which was generated against a synthetic peptide from amino acid region 200-245 of mouse Taar1 conjugated to blue carrier protein (1: 50; ABIN 351020, Antibodies Online, Aachen, Germany). Cells were colabelled with mouse anti-rat acetylated α-tubulin (1: 50; T7451, Sigma-Aldrich) antibodies, or treated with 10 μg/ml of biotin-conjugated Concanavalin A (ConA) from Canavalia ensiformis (C2272, Sigma-Aldrich) for 30 min at 4 ° C. After washing with 0.1% BSA in CMF-PBS, the cells or sections were incubated with Alexa 488-or Alexa 546-conjugated secondary antibodies (1: 200; A11070 and A11018, respectively; Molecular Probes, Karlsruhe, Germany) for 1 h at 37 ° C together with 5 μ M of the nuclear counterstain Draq5 TM (Biostatus Limited, Shepshed, UK). Specific antibodies were omitted in negative controls. Alternatively, lectin-stained cells were incubated with the Alexa Fluor ® 546-conjugated streptavidin (S-11225, Molecular Probes) as the secondary ConA detection label. After washing with CMF-PBS and deionized water, the sections and the cells on coverslips were mounted with embedding medium consisting of 33% glycerol, 14% Mowiol in 200 m M Tris-HCl, pH 8.5 (Hoechst AG, Frankfurt, Germany).
Samples were analyzed with a confocal laser scanning microscope equipped with Argon and Helium-Neon lasers (LSM 510 Meta; Carl Zeiss Jena GmbH, Jena, Germany). Images were obtained at a pinhole setting of 1 Airy unit and at a resolution of 1,024 × 1,024 pixels. Micrographs were analyzed with the LSM 510 software, release 3.2 (Carl Zeiss Jena GmbH). Staining and inspection of WT and taar1 -deficient mouse thyroid tissue was performed under identical conditions on the same day to ensure maximal comparability of labeling.
Immunoblotting
Thyroid tissue from BALB/c and C57BL6/J mice as well as taar1 -deficient mice on the C57BL6/J background was lysed in Triton-X 100 in PBS supplemented with a protease inhibitor cocktail, and protein determination was performed by the Neuhoff method using BSA as a standard [25] . Samples were loaded onto 12.5% SDS-polyacrylamide gels and semi-dry blotted onto nitrocellulose membranes, which were incubated with rabbit anti-mouse Taar1 antibodies (see above) at a dilution of 1: 500 and horseradish peroxidase-conjugated secondary antibodies at a dilution of 1: 5,000 before visualization by chemiluminescence onto XPosure film.
Results
Taar1 Immunostaining in Mouse and Rat Thyroid Tissue
Immunofluorescence was observed in lumen-apposed apical plasma membrane domains ( fig. 1 , arrowheads) and in reticular and vesicular structures ( fig. 1 , arrows) present in the cytoplasm of cryosectioned thyroid follicle cells prepared from WT C57BL6/J mice and Fisher rat thyroid tissue using a polyclonal rabbit anti-mouse Taar1 antiserum. In contrast, identically treated cryosections prepared from taar1 -deficient mouse thyroid tissue exhibited weak to no immunoreactivity ( fig. 1 a) , demonstrating the antiserum's specificity in immunofluorescence applications.
Immunoblotting revealed several bands in tissue lysates, including a band with an apparent molecular mass of approximately 38 kDa, as expected for Taar1, which was identified in thyroid tissue from BALB/c and C57BL6/J mice, whereas this band was almost absent from taar1 -/-mouse thyroid tissue (not shown).
Taar1 Immunodetection by Differential Permeabilization of FRT Cells
We next investigated the subcellular localization and trafficking pathways of Taar1 in FRT cells by immunofluorescence labeling and confocal laser scanning microscopy. As the polyclonal rabbit anti-Taar1 antibodies were generated against an epitope in the third cytoplasmic loop of Taar1 (see above), we wanted to be sure the antibodies could penetrate the plasma membrane of FRT cells. Therefore, formaldehyde was used as a noncrosslinking fixative, and differential permeabilization experiments were conducted with saponin as a milder alternative to the stronger detergent Triton X-100 to promote the detection of intracellular structures more readily [26] .
When confluent FRT cells were subjected to fixation without permeabilization, anti-Taar1 antibodies reacted with small punctate and disc-like structures that were detectable in a focal plane slightly above the monolayers ( fig. 2 a, a′). Such structures were prominent and more broadly labeled when FRT cells were fixed and saponin permeabilized ( fig. 2 b, b′). These results suggested the presence of Taar1 at appendages of the apical poles of FRT cells in monolayer cultures. When Triton X-100 was used as the detergent, many of the disc-like appendages were still immunolabeled, while additional structures with a reticular and vesicular appearance were detected as well ( fig. 2 c, c′) . The differential permeabilization of formaldehyde-fixed FRT cell monolayers therefore provided further evidence in support of Taar1 being an integral membrane protein at the apical pole of the thyroid epithelial cells.
Taar1 Distribution in Compartments of the Secretory Route
Immunolabeling of confluent monolayer cultures of FRT cells following fixation and saponin permeabilization revealed distinct patterns of Taar1 localization ( fig. 3 a, b) , indicating heterogeneity of Taar1 distribution across the cell population. That is, all cells of the FRT monolayer exhibited Taar1 immunoreactivity, but it was localized to different subcellular compartments under steady-state conditions. In particular, Taar1 immunoreactivity was localized within the endoplasmic reticulum (ER; fig. 3 c) . Moreover, cisternal structures in the juxtanuclear region of FRT cells were immunoreactive for Taar1 ( fig. 3 d) . Interestingly, Taar1-immunopositive vesicle-like structures were prominently observed to cluster at the borders of FRT cells in dense monolayer cultures ( fig. 3 e, arrows) , suggesting that Taar1 protein is present in transport vesicles in transit to -or arriving at -the plasma membrane. Finally, the already described disclike structures ( fig. 2 ) , typically one per cell and focally above the microtubule-organizing center next to the nucleus, were detected by the anti-Taar1 antiserum ( fig. 3 a,  b , f, f′, arrowheads). Viewed using confocal imaging, the stacks consisting of single focal planes, taken at a distance of 0.3 μm and displayed in the xz direction as side views, revealed a prominent Taar1-containing cellular extension reminiscent of a cilium at the apical pole of the cells, with several shorter and thinner microvilli-like extensions occasionally observed as well ( fig. 3 f, f′) . Incubation with the fluid-phase marker LysoTracker Red DND-99 demonstrated anti-Taar1-positive structures were not present in compartments of the endocytic pathway ( fig. 3 f-f5 ).
Taar1 Immunoreactivity Is Present in the Plasma Membrane of FRT Cell Cilia
To confirm that Taar1 is present in the plasma membrane of FRT cells, the anti-Taar1 polyclonal antiserum was used in combination with streptavidin to detect cell surface-bound biotinylated ConA. This lectin binds to α-mannopyranosyl and α-glucopyranosyl residues of carbohydrate side-chains of membrane constituents and, consistent with the previous findings, Taar1-immunoreactivity (green) colocalized with ConA (red) in a structure that formed a cilia-like extension above the lectin-stained cell surface ( fig. 4 a, a′) . That these extensions were indeed primary cilia was confirmed based on the copresence of the well-established cilia marker acetylated α-tubulin [27, 28] and Taar1 immunoreactivity ( fig. 4 b, b′) . 
Taar1 Expression and Cilia Localization Is Maintained upon Formation of Domes and Follicle-Like Structures
In long-term cultures, FRT cells retain their morphological polarization with apical and basolateral plasma membrane domains because they express proteins involved in the formation of tight junctions. Furthermore, once confluence is reached, FRT cells can undergo additional differentiation characterized by the formation of 'domes' observed in postconfluent, long-term cultures, which eventually convert into follicle-like structures (FLS) [29] . FLS resemble thyroid follicles in situ and thus provide an excellent in vitro model for studying protein trafficking with regard to the apical versus basolateral distribution of transmembrane proteins in thyrocytes in situ. Consequently, we examined Taar1 localization in assembled FLS as a function of long-term FRT cell culture. In such cultures Taar1 immunoreactivity was localized at the plasma membrane domain associated with the follicular lumen ( fig. 5 a, b, arrows) , i.e. at the future apical plasma membrane domain of cells in the FLS. Thus, Taar1 trafficking was reversed while the monolayer lifted up for dome formation (for a schematic illustration, see fig. 5 a′) . However, the cells migrating underneath the domes kept their apical Taar1 localization in cilia pointing toward the future FLS lumen ( fig. 5 a, b) . Additionally, we observed that among individual cells of FLS, some were characterized by an enhanced expression of Taar1 ( fig. 5 a, c, d, arrowheads) , which underscored the heterogeneous nature of Taar1 expression in individual cells of long-term cultures of the Fisher rat thyroid epithelial FRT cells.
Discussion
Intriguingly, T 1 AM and T 0 AM, the deiodinated and decarboxylated molecular relatives of classic TH [30] , have been proposed to be the endogenous ligands of Taar1 [12] , a conjecture supported by studies where synthetic thyronamines significantly influenced whole animal and cellular physiology [for reviews, see 7, 10, 13 ] . Despite these provocative findings, the contribution of Taar1 and T 1 AM to thyroid homeostasis is poorly understood. Consequently, to bridge this gap in our knowledge we designed and conducted the present study to determine: (1) whether Taar1 is expressed in the thyroid glands of WT mice and rats; (2) whether Taar1 is expressed in the rat thyroid epithelial cell line FRT, and (3) if Taar1 expression is detected, what is its subcellular localization?
Taar1 in Primary Cilia at the Apical Surface of Polarized Thyroid Epithelial Cells
Data on the subcellular localization of Taar1 in potential target cells -including thyroid epithelial cellsare rare due, in part, to it being an intrinsic, low-abundance, poorly immunogenic membrane protein. These obstacles were overcome in the present study by our use of immunofluorescence microscopy to compare Taar1 immunoreactivity present in taar1 -deficient mice to immunoreactivity in thyroid tissue prepared from WT mice, Fisher rats and FRT cells. This approach allowed us to establish the specificity of the commercially generated (Antibodies Online) polyclonal rabbit anti-mouse Taar1 antibody used, and revealed the intracellular distribution pattern of Taar1 immunoreactivity in the secretory pathway of FRT cells. The most noteworthy observation was the colocalization of Taar1 immunostaining with the cilia marker acetylated α-tubulin on the apically located primary cilium of FRT cells. Long-term cultures of FRT cells were also investigated in our study because this cell line is known to form 'domes' that actively pump ions, solute and water, and thus start to lift up from the bottom of the culture dish. They initially form half-spheres that can then transit into 'thyroid fol- licle-like' structures [29] , eventually capable of forming multicellular, follicle-like spheres. Within such FLS (see fig. 5 ), FRT cells maintain their highly polarized phenotype that is also typical for adequately cultured, signaling-competent porcine or human thyrocytes [31] [32] [33] , and thyroid epithelial cells in situ. In the present study, three-dimensional, high-resolution confocal fluorescence imaging revealed anti-Taar1 antibody-positive cilia at the apical pole of thyroid epithelial cells to be maintained in the thyroid follicle-like spheres. Interestingly, Taar1 immunoreactivity differed significantly between individual FRT cells of thyroid FLS in culture. This observation was not completely unexpected as it has been reported that epithelial cells constituting thyroid follicles in situ are heterogeneous [34, 35] . Although this phenomenon is well documented, the molecular mechanism(s) underlying such distinctions between thyroid epithelial cells of one lineage, that is within one follicle, remain unclear [35] [36] [37] [38] [39] [40] .
Taar1 Trafficking to Reach Primary Cilia of Thyrocytes
GPCRs are known to be expressed in small amounts [41] . Accordingly, it is assumed that only few ligand and receptor molecules are sufficient to mediate ligand-triggered signaling via G-proteins either at the plasma membrane or by intracellular signaling microdomains [42] . Hence, it was proposed that GPCR signaling depends on their assembly in specific subdomains of the plasma membrane, such as lipid raft-like microdomains or in cilia [43] [44] [45] . Indeed, the findings of our present study support the interpretation that the Taar1 protein is targeted to and follows the secretory pathway to reach cilia at the apical plasma membrane domain of thyroid epithelial cells in situ and in vitro. The molecular determinants of Taar1 trafficking are presently unknown, but it is conceivable that targeting sequences exist similar to those functioning in other ciliary-located GPCRs [46] . Taar1 accumulates in easily detectable, antenna-like structures extending from polarized FRT cells into the extracellular milieu (see fig. 3-5 ). The assembly of such antenna-resembling cilia depends on intraflagellar transport which is required for elongation of the axoneme and codetermines the protein composition of the cilial plasma membrane [45, 47] . In keeping with this notion, primary cilia are currently viewed as providing a privileged environment for signaling in which GPCRs assemble in a concentrated fashion. Moreover, small molecules and ions become enriched in cilia relative to the cytoplasm by several orders of magnitude, even though a diffusion barrier, for example by molecular fences, is absent [45] .
It was recently described that Taars other than Taar1 are uniquely localized on cilia of specific olfactory neurons [48] . This neural cell type (with stem cell properties) bears a number of cellular appendages, thereby harboring multiple dendrite-like cilia per cell, which extend b a Fig. 6 . Schematic representation of the putative location of thyronamine generation and contribution to autoregulation of the thyroid gland. Thyronamines can, in principle, be generated by extraor intrathyroidal means which involve deiodination and decarboxylation of iodothyronines generated by the degradation of thyroglobulin within the thyroid follicles ( a ). Thyroglobulin degradation is mediated by cysteine cathepsins B, K, L, and/or S, starting in the extracellular follicle lumen and continuing in the compartments of the endocytic pathway [17, 19] . If generated by extrathyroidal means, thyronamines need to be imported by unknown transporter molecules (black boxes). Since TH deiodination is catalyzed by integral membrane enzymes and decarboxylation for generation of thyronamines is a cytosolic process, thyronamine transporters must also be present at the endolysosomal and the plasma membranes of thyrocytes, if thyronamines are generated by intrathyroidal means ( b ). from the cell surface into air at the neuro-epithelium-air interface in the nasal cavity. In clear contrast, it is important to note that Taar1 is present in the primary cilium of thyroid epithelial cells, as detected in this study. Primary cilia are formed by many cell types; typically only one copy is present per cell, which is also the case for thyrocytes [31, 44, 49, 50] . To our knowledge, no reports have been presented on GPCRs localized to the apical plasma membrane domain of thyroid epithelial cells.
We determine that the ciliated apical plasma membrane domain of thyroid epithelial cells bears critical functions in that it harbors the means for formation of iodothyronines during TH generation while also serving as a platform of initial cysteine cathepsin-mediated thyroglobulin processing for TH liberation [16] [17] [18] [19] . Hence, the localization of Taar1 in the primary cilium at the apical plasma membrane domain of thyroid epithelial cells in vitro and in situ provides the source for novel hypotheses in thyroid cell biology. Moreover, the presence of Taar1 in a hair-like extension reaching out into the juxtamembrane thyroglobulin-filled thyroid follicle lumen, where the precursors (TH) of its ligands (thyronamines) are liberated, implies a possible involvement of Taar1 in thyroid autoregulation. We hypothesize that Taar1 may serve an important sensory function to detect changes in the molecular composition of the thyroid follicle lumen. However, the suggested hypotheses will have to be sustained by further experiments.
Likewise, physiologically relevant intrathyroidal ligands of Taar1 need to be identified in the future. Besides 3-T 1 AM, another interesting candidate -also known as an activating Taar1 ligand -is tyramine [51] , which was previously proposed to be involved in the generation of H 2 O 2 at the apical pole of thyrocytes [52, 53] . However, an answer to the open question as to which of the biogenic amines that are known to trigger Taar1 in vitro may be important in situ for thyroid regulation depends on the availability of methods to qualitatively and quantitatively determine the amounts of intrathyroidal biogenic amines.
Thyronamines and Taar1 in Thyroid Autoregulation
Arguably, the central question in the T 1 AM field has to do with its physiological role(s) in healthy and diseased states. This fundamental question remains unanswered, in part, due to the fact that the molecular mechanisms of thyronamine (e.g. T 1 AM) generation are not known. Although the location of T 1 AM/T 0 AM production is thought to occur in extrathyroidal tissue in T 4 -substituted (athyreotic) humans [54] , this interpretation is still controversial, especially for rodents. Furthermore, although it has been isolated from tissue [12, 14] , the enzymes responsible for T 1 AM generation remain elusive [55] . While deiodination of TH has been studied intensely, including those in the thyroid gland itself [56] , only a few investigations have attempted to identify the thyronamine-generating decarboxylating enzyme [57] and its tissue location, which remains enigmatic. It is known, however, that 125 I-labeled T 1 AM added exogenously through injection into the blood circulation of BALB/c mice results in the accumulation of 125 I-radioactivity in the thyroid gland, where it persists with a long half-life and can be competed with excess nonradioactive T 1 AM, suggesting specificity of thyroidal uptake [58] . These findings suggest that T 1 AM or metabolites derived therefrom may act as a potentially important ligand of intrathyroidal Taar1 in situ.
In this context, our observation of Taar1 in subcellular compartments associated with the secretory pathway, in addition to cilia at the apical pole of the structurally polarized thyroid epithelial cells, raises interesting possibilities with regard to possible T 1 AM-triggered, Taar1-mediated physiological responses of the thyroid gland (see fig. 6 ). One exciting corollary is that thyronamines (e.g. T 1 AM) are generated within the thyroid gland, as are classical TH. Therefore, based on our present findings, we here propose a scenario wherein the thyronamines trigger responses of thyrocytes in the thyroid gland via stimulation of apically located Taar1. As schematically sketched in figure 6 , T 1 AM could be generated within the thyroid follicle lumen to be in reach of the apically located Taar1 receptors. This scenario would explain how T 1 AM could act as an agonist of Taar1 expressed on the apical poles of thyroid epithelial cells.
In summary, the results of this study provide novel hypotheses for a potential role of Taar1-mediated signaling in thyroid autoregulation by demonstrating the presence of Taar1 on the primary cilium at the apical pole of thyroid epithelial cells. In the future it will be important to determine whether or not T 1 AM or T 0 AM, or other thyroid-relevant biogenic amines, are able to trigger Taar1 actions in FRT cells. In this context it will also be informative to determine whether an iodothyronine decarboxylating activity is present in rat thyroid epithelial cells. Studies of this kind should eventually help to establish whether and to what extent T 1 AM-Taar1 interactions contribute to the autoregulation of the thyroid gland in health and disease.
